Sodium/glucose co transporter 2 (SGLT2) inhibitors and the risk of diabetic ketoacidosis

被引：0
|
作者：
Ahmad, M. [1 ]
Hegde, P. [1 ]
Weston, P. [1 ]
机构：
[1] Royal Liverpool Univ Hosp, Ctr Diabet, Liverpool, Merseyside, England
来源：
DIABETIC MEDICINE | 2017年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P217
引用
收藏
页码：98 / 98
页数：1
相关论文
共 50 条
  • [1] SGLT2 inhibitors and the risk of diabetic ketoacidosis
    Redford, Christopher
    Doherty, Laura
    Smith, Jamie
    PRACTICAL DIABETES, 2015, 32 (07) : 263 - 264A
  • [2] Risk of diabetic ketoacidosis with SGLT2 inhibitors
    Reactions Weekly, 2015, 1566 (1) : 1 - 1
  • [3] SGLT2 inhibitors increase the risk of diabetic ketoacidosis
    Reactions Weekly, 2016, 1603 (1) : 9 - 9
  • [4] Individual SGLT2 Inhibitors and the Risk of Diabetic Ketoacidosis
    Abrahami, Devin
    D'Andrea, Elvira
    Kim, Seoyoung C.
    Wexler, Deborah J.
    Paik, Julie M.
    Patorno, Elisabetta
    DIABETES, 2022, 71
  • [5] SGLT2 inhibitors increase risk of diabetic ketoacidosis
    Reactions Weekly, 2017, 1656 (1) : 12 - 12
  • [6] Diabetic ketoacidosis with SGLT2 inhibitors
    Musso, Giovanni
    Saba, Francesca
    Cassader, Maurizio
    Gambino, Roberto
    BMJ-BRITISH MEDICAL JOURNAL, 2020, 371
  • [7] The unexpected benefits of sodium glucose co-transporter 2 (SGLT2) inhibitors
    Chan, Chok G.
    Stewart, Ralph
    NEW ZEALAND MEDICAL JOURNAL, 2022, 135 (1560) : 99 - 104
  • [8] Fournier's Gangrene and Diabetic Ketoacidosis Associated with Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors: Life-Threatening Complications
    Kasbawala, Kinjal
    Stamatiades, George A.
    Majumdar, Sachin K.
    AMERICAN JOURNAL OF CASE REPORTS, 2020, 21 : 1 - 4
  • [9] SGLT2 inhibitors and euglycemic diabetic ketoacidosis
    Yousaf, Zohaib
    Ata, Fateen
    Khan, Adeel Ahmad
    Razok, Almurtada
    Akram, Jaweria
    Ali, Elrazi Awadelkarim Hamid
    Abdalhadi, Ahmed
    Danjuma, Mohammed I.
    Al Mohanadi, Dabia Hamad S. H.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (09) : 1431 - 1433
  • [10] SGLT2 inhibitors and euglycemic diabetic ketoacidosis
    Zohaib Yousaf
    Fateen Ata
    Adeel Ahmad Khan
    Almurtada Razok
    Jaweria Akram
    Elrazi Awadelkarim Hamid Ali
    Ahmed Abdalhadi
    Mohammed I. Danjuma
    Dabia Hamad S. H. Al Mohanadi
    European Journal of Clinical Pharmacology, 2021, 77 : 1431 - 1433
12345